Skip to main navigation Skip to search Skip to main content

The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease

  • Senthilkumar S. Karuppagounder
  • , Saurav Brahmachari
  • , Yunjong Lee
  • , Valina L. Dawson
  • , Ted M. Dawson
  • , Han Seok Ko
  • Johns Hopkins University
  • Adrienne Helis Malvin Medical Research Foundation
  • Diana Helis Henry Medical Research Foundation

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience